162 related articles for article (PubMed ID: 19107782)
1. Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: a case-control study.
Hanson KA; Loftus EV; Harmsen WS; Diehl NN; Zinsmeister AR; Sandborn WJ
Inflamm Bowel Dis; 2009 May; 15(5):772-7. PubMed ID: 19107782
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis, characterization, and 3-month outcome after detoxification of 39 patients with narcotic bowel syndrome.
Drossman DA; Morris CB; Edwards H; Wrennall CE; Weinland SR; Aderoju AO; Kulkarni-Kelapure RR; Hu YJ; Dalton C; Bouma MH; Zimmerman J; Rooker C; Leserman J; Bangdiwala SI
Am J Gastroenterol; 2012 Sep; 107(9):1426-40. PubMed ID: 22710577
[TBL] [Abstract][Full Text] [Related]
3. Narcotic use for inflammatory bowel disease and risk factors during hospitalization.
Long MD; Barnes EL; Herfarth HH; Drossman DA
Inflamm Bowel Dis; 2012 May; 18(5):869-76. PubMed ID: 21739533
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of chronic narcotic use among children with inflammatory bowel disease.
Buckley JP; Cook SF; Allen JK; Kappelman MD
Clin Gastroenterol Hepatol; 2015 Feb; 13(2):310-315.e2. PubMed ID: 25117776
[TBL] [Abstract][Full Text] [Related]
5. Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study.
Choung RS; Locke GR; Zinsmeister AR; Schleck CD; Talley NJ
Am J Gastroenterol; 2009 May; 104(5):1199-204. PubMed ID: 19367263
[TBL] [Abstract][Full Text] [Related]
6. Narcotic use in patients with Crohn's disease.
Cross RK; Wilson KT; Binion DG
Am J Gastroenterol; 2005 Oct; 100(10):2225-9. PubMed ID: 16181373
[TBL] [Abstract][Full Text] [Related]
7. The burden of comedication among patients with inflammatory bowel disease.
Buckley JP; Kappelman MD; Allen JK; Van Meter SA; Cook SF
Inflamm Bowel Dis; 2013 Dec; 19(13):2725-36. PubMed ID: 24216689
[TBL] [Abstract][Full Text] [Related]
8. The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis.
Targownik LE; Nugent Z; Singh H; Bugden S; Bernstein CN
Am J Gastroenterol; 2014 Oct; 109(10):1613-20. PubMed ID: 25178702
[TBL] [Abstract][Full Text] [Related]
9. Robust Association Between Inflammatory Bowel Disease and Generalized Anxiety Disorder: Findings from a Nationally Representative Canadian Study.
Fuller-Thomson E; Lateef R; Sulman J
Inflamm Bowel Dis; 2015 Oct; 21(10):2341-8. PubMed ID: 26218145
[TBL] [Abstract][Full Text] [Related]
10. Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics.
Edwards JT; Radford-Smith GL; Florin TH
J Gastroenterol Hepatol; 2001 Nov; 16(11):1235-8. PubMed ID: 11903741
[TBL] [Abstract][Full Text] [Related]
11. Is narcotic addiction more prevalent in IBD patients?
Freeman HJ
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S56. PubMed ID: 18816785
[No Abstract] [Full Text] [Related]
12. Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study.
Ricart E; Panaccione R; Loftus EV; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ
Inflamm Bowel Dis; 2004 May; 10(3):207-14. PubMed ID: 15290913
[TBL] [Abstract][Full Text] [Related]
13. Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011.
Narula N; Borges L; Steinhart AH; Colombel JF
Inflamm Bowel Dis; 2017 Jun; 23(6):868-874. PubMed ID: 28368911
[TBL] [Abstract][Full Text] [Related]
14. Dental Caries and Periodontal Disease in Children and Adolescents with Inflammatory Bowel Disease: A Case-Control Study.
Koutsochristou V; Zellos A; Dimakou K; Panayotou I; Siahanidou S; Roma-Giannikou E; Tsami A
Inflamm Bowel Dis; 2015 Aug; 21(8):1839-46. PubMed ID: 25985243
[TBL] [Abstract][Full Text] [Related]
15. Narcotic use and misuse in Crohn's disease.
Crocker JA; Yu H; Conaway M; Tuskey AG; Behm BW
Inflamm Bowel Dis; 2014 Dec; 20(12):2234-8. PubMed ID: 25208105
[TBL] [Abstract][Full Text] [Related]
16. Pain in Inflammatory Bowel Disease Is Not Improved During Hospitalization: The Impact of Opioids on Pain and Healthcare Utilization.
Berry SK; Takakura W; Bresee C; Melmed GY
Dig Dis Sci; 2020 Jun; 65(6):1777-1783. PubMed ID: 31654314
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.
Biancone L; Armuzzi A; Scribano ML; D'Inca R; Castiglione F; Papi C; Angelucci E; Daperno M; Mocciaro F; Riegler G; Fries W; Meucci G; Alvisi P; Spina L; Ardizzone S; Petruzziello C; Ruffa A; Kohn A; Vecchi M; Guidi L; Di Mitri R; Renna S; Emma C; Rogai F; Rossi A; Orlando A; Pallone F;
J Crohns Colitis; 2016 Aug; 10(8):913-24. PubMed ID: 26933032
[TBL] [Abstract][Full Text] [Related]
18. Persistent opioid use after radiation therapy in opioid-naive cervical cancer survivors.
Ward K; Ramzan A; Sheeder J; Fischer S; Lefkowits C
Int J Gynecol Cancer; 2019 Sep; 29(7):1105-1109. PubMed ID: 31420413
[TBL] [Abstract][Full Text] [Related]
19. Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease.
Leung YP; Kaplan GG; Coward S; Tanyingoh D; Kaplan BJ; Johnston DW; Barkema HW; Ghosh S; Panaccione R; Seow CH; ;
J Crohns Colitis; 2015 Mar; 9(3):223-30. PubMed ID: 25576754
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4-year Prospective Study.
Hashash JG; Chintamaneni P; Ramos Rivers CM; Koutroubakis IE; Regueiro MD; Baidoo L; Swoger JM; Barrie A; Schwartz M; Dunn MA; Binion DG
Inflamm Bowel Dis; 2015 Nov; 21(11):2576-82. PubMed ID: 26296061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
